The authors are thankful to the staff of the Bafia health district for their contributions, and to the participants for their cooperation. We also wish to acknowledge Scott Elder and Holly Chastain from the Centers for Disease Control and Prevention (CDC) in USA for having provided Recombinant AbD19432 antibodies. Joseph Kamgno and Linda Djune Yemeli are members of the Central Africa Clinical Research Network (CANTAM) supported by European and Developing Countries Clinical Trial Partnership (EDCTP) programme.